EUVIMEDEUVIMED entdecken
Crossref

Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly

Wei Lin iD, Songchang Shi, Yuanyuan Zheng, Edward Laws, Timothy R Smith, Le Min iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Wei Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Machine Learning, Acromegaly, Receptors, Somatostatin, Drug Resistance. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Acromegaly, caused by excess GH and IGF-1 due to pituitary adenomas, often necessitates first-generation somatostatin receptor ligands (fgSRLs) therapy when surgery fails. However, responses to fgSRLs therapy vary widely.

Objective

To develop a machine learning (ML)-based calculator that predicts individual responses to fgSRLs therapy, enabling evidence-based acromegaly management.

Design

A retrospective study (January 2010-July 2024) utilizing the Research Patient Data Registry to evaluate 10 ML algorithms and create a predictive calculator.

Setting

Single-center study conducted at Mass General Brigham-affiliated hospitals. Patients One hundred eleven acromegaly patients met inclusion criteria, classified as fgSRLs-responsive (n = 64) or fgSRLs-resistant (n = 47).

Interventions

IGF-1 trajectories were analyzed using linear mixed-effects modeling. Ten ML algorithms were assessed to predict fgSRLs resistance. SHapley Additive exPlanations (SHAP) analysis identified key predictors for the development of a web-based clinical calculator. Main Outcome Measures Model performance was primarily evaluated using area under the receiver operating characteristic curve (AUROC), along with accuracy, precision, recall, specificity, F1 score, and decision curve analysis (DCA).

Results

The CatBoost model exhibited optimal performance based on AUROC 0.896 (95% confidence interval: 0.751-0.990), with accuracy 82.4%, precision 86.7%, specificity 88.2%, and F1 score 81.2%. Key predictors of fgSRLs resistance identified via SHAP analysis included pre-fgSRLs treatment GH, Knosp grade, pre-fgSRLs treatment IGF-1 index, T2-weighted magnetic resonance imaging density, and comorbidity burden. The model demonstrated excellent calibration (Brier score 0.131) and clinical utility via DCA. A web-based calculator was developed for clinical use.

Conclusion

The CatBoost-based calculator effectively predicts fgSRLs treatment response in acromegaly patients. Prospective validation is required before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAcromegalyReceptors, SomatostatinDrug ResistanceAdenomaHumansFemaleMaleRetrospective StudiesMiddle AgedAdultLigandsInsulin-Like Growth Factor IHuman Growth HormoneAgedPrognosisAlgorithms

Stichwörter der Autor:innen

acromegalyfirst-generation somatostatin receptor ligandmachine learningpersonalized medicineweb-based clinical calculator

Substanzen

Receptors, SomatostatinLigandsInsulin-Like Growth Factor IHuman Growth HormoneIGF1 protein, human

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Endocrinology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian 350001, P. R. China.
  • Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital South Branch, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital,…
  • Department of Geriatric Medicine, Fujian Key Laboratory of Geriatrics Diseases, Fujian Provincial Center for Geriatrics, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian 350001, P. R. China.
  • Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Wei Lin, Le Min

Förderung

  • Pfizer

Zitieren

APA

Lin, W., Shi, S., Zheng, Y., Laws, E., Smith, T. R., & Min, L. (2026). Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf375

Vancouver

Lin W, Shi S, Zheng Y, Laws E, Smith TR, Min L. Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf375

BibTeX
@article{Lin2026,
  author = {Lin, Wei and Shi, Songchang and Zheng, Yuanyuan and Laws, Edward and Smith, Timothy R and Min, Le},
  title = {Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf375}
}
Kostenlos starten →